1. Home
  2. EPSN vs FATE Comparison

EPSN vs FATE Comparison

Compare EPSN & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$4.42

Market Cap

132.1M

Sector

Energy

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

124.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPSN
FATE
Founded
2005
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.1M
124.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
EPSN
FATE
Price
$4.42
$1.17
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.92
AVG Volume (30 Days)
158.1K
1.8M
Earning Date
11-05-2025
03-04-2026
Dividend Yield
5.67%
N/A
EPS Growth
11.33
N/A
EPS
0.27
N/A
Revenue
$45,709,605.00
$7,137,000.00
Revenue This Year
$41.35
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.49
N/A
Revenue Growth
46.76
N/A
52 Week Low
$4.20
$0.66
52 Week High
$8.50
$1.94

Technical Indicators

Market Signals
Indicator
EPSN
FATE
Relative Strength Index (RSI) 43.16 57.64
Support Level $4.31 $1.02
Resistance Level $4.59 $1.22
Average True Range (ATR) 0.19 0.06
MACD 0.00 0.02
Stochastic Oscillator 32.84 74.38

Price Performance

Historical Comparison
EPSN
FATE

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: